(InjuryBoard.com) A new study has found that iodine-based radiographic dye that doctors use to increase contrast during medical scans can damage the thyroid gland in some patients.

Every year, millions of people worldwide receive a radiographic iodide dye called iodinated contrast media (ICM) for imaging procedures such as cardiac catheterization and computed tomography scans (CT scans). Healthcare providers usually inject iodinated contrast media intravenously, but may also administer it intraarterially, intrathecally or intraabdominally. Iodide is a form of iodine. The iodide in a typical dose of iodinated contrast media for a scan is hundreds of times greater than the recommended daily allowance of iodine. Adverse effects of iodinated contrast media on the kidneys are a known risk. However, not much research is available on the effects of it on the thyroid gland. The thyroid requires iodine to manufacture its hormones, but an overabundance or deficiency of iodine can cause thyroid problems.

Authors analyzed medical records of patients treated between 1990 and 2010 who had no preexisting hyperthyroidism (an overactive thyroid) or hypothyroidism (an underactive thyroid). The study showed that patients who developed hyperthyroidism or hypothyroidism were two to three as likely as those who did not develop the conditions to have received an iodinated contrast media during a CT scan or cardiac catheterization. “We were very surprised by the magnitude of the associations,” study author Dr. Steven M. Brunelli, of Brigham and Women’s Hospital in Boston told The New York Times. “We obviously expected to find something or we wouldn’t have embarked on the study. But to see these twofold or even threefold changes in risk was more than we had expected.”

Post Continues on InjuryBoard.com